Countdown to ASH 2024: What to Expect in Breakthroughs in Hematology-Oncology The 66th American Society of Hematology (ASH) Annual Meeting is almost here, from December 7-10 in San Diego and online! This year’s gathering will be packed with groundbreaking developments in hematology and oncology. Here’s a glimpse into some of the highly anticipated presentations from industry frontrunners—just a few among hundreds of exciting advancements that will Read more
AI in Clinical Trials: 8 Groundbreaking Innovations That Defined the Year As the new year unfolds, the field of clinical research is charging forward with a wave of powerful innovations, driven by the integration of artificial intelligence. In the past year alone, AI has demonstrated its potential to redefine key aspects of drug development—from patient recruitment to protocol optimization. These innovations are not just enhancing efficiency Read more
Advancing Lung Cancer Care: New Treatment Insights Highlighted During Awareness Month As Lung Cancer Awareness Month brings attention to the disease, the impact of lung cancer worldwide remains grave, with around 1.8 million lives lost each year. Recent findings in cancer research bring encouraging news: a new combination therapy of amivantamab and lazertinib offers a substantial improvement for those with advanced non-small cell lung cancer (NSCLC). Read more
World Diabetes Day Focus: The Role of GLP-1 Agonists and SGLT2 Inhibitors in Diabetes Treatment Key takeaways: GLP-1 Agonists and SGLT2 Inhibitors are two effective medication classes for managing Type 2 diabetes, each offering unique benefits. GLP-1 Agonists (e.g., Ozempic) provide significant blood sugar control and weight loss, ideal for patients prioritizing weight management. SGLT2 Inhibitors (e.g., Jardiance) offer strong heart and kidney protection, often recommended for patients with heart Read more
